CLINICAL_TRIALS
trial_result
· 2009-11-13
Clinical Trial Update: Neoadjuvant Chemoradiation With RHUMAB VEGF (Avastin) for Rectal Cancer [Phase 2]
Summary
Phase 2 study evaluating neoadjuvant chemoradiation with bevacizumab (Avastin) for rectal cancer; results were posted in 2009.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Rectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2009-11-13